An anonymous director reports
HALO TO POSTPONE REPORTING INTERIM FINANCIAL RESULTS DUE TO DELAYS CAUSED BY THE COVID-19 PANDEMIC
Due to delays caused by the COVID-19 pandemic, Halo Labs Inc. is relying on the exemption provided in Ontario Instrument 51-505 (Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to Aug. 31, 2020, of the Ontario Securities Commission) (and similar exemptions provided by other Canadian securities regulators) to postpone the filing of the following continuous disclosure documents:
-
The company's interim financial statements for the three and six months ended June 30, 2020, as required by Section 4.4(a) of National Instrument 51-102 (Continuous Disclosure Obligations);
- The company's management's discussion and analysis for the three and six months ended June 30, 2020, as required by Subsection 5.1(2) of NI 51-102.
The instrument provides the company with an additional 45 days from the deadline otherwise applicable under Ontario securities laws to make the filing. The company's management and other insiders are subject to a trading blackout, reflecting the principles contained in Section 9 of National Policy 11-207 (Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions).
The company expects to file the disclosure documents on or prior to Aug. 18, 2020.
The company confirms that, other than as disclosed in prior press releases, there have been no additional material business developments since the filing on June 19, 2020, of the company's interim financial report for the three months ended March 31, 2020.
About Halo Labs Inc.
Halo is a leading cannabis cultivation, manufacturing and distribution company that grows, extracts and processes quality cannabis flower, oils and concentrates, and has sold over five million grams of oils and concentrates since inception. Additionally, Halo has continued to evolve its business through delivering value with its products and now through verticalization in key markets in the United States and Africa with planned expansion into European and Canadian markets. With a consumer-centric focus, Halo markets innovative, branded and private label products across multiple product categories.
Recently, the company entered into a binding letter of intent to acquire Canmart Ltd., which holds wholesale distribution and special licences, allowing the import and distribution of cannabis-based products for medicinal use (CBPMs) in the United Kingdom. Halo is led by a strong, diverse management team with deep industry knowledge and blue-chip experience. The company is currently operating in the United States in California, Oregon and Nevada while having an international presence in Lesotho within a planned 205-hectare cultivation zone through Bophelo Bioscience & Wellness Pty. Ltd., as well as planned importation and distribution in the United Kingdom through Canmart.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.